Purchases and Sales Made in Q2 2022 in Vincerx Pharma, Inc. (VINC)
This table provides information about the institutional ownership of Vincerx Pharma, Inc. (VINC) during Q2 2022. The information is specifically focused on institutions that hold shares of Vincerx Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-86.6K- 13.0% |
$0 - $0
|
579K
$313K
|
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-114K- 81.65% |
$0 - $0
|
25.7K
$13.9K
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-132K- 49.08% |
$0 - $0
|
137K
$74.1K
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-156K- 78.37% |
$0 - $0
|
43.1K
$23.3K
|
|
|
Jul 29, 2022
Q2 2022
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-227KClosed |
$0 - $0
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-629K- 81.53% |
$0 - $0
|
142K
$76.9K
|
|
|
Aug 15, 2022
Q2 2022
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-650K- 90.22% |
$0 - $0
|
70.5K
$38.1K
|
|
|
Aug 15, 2022
Q2 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-1.38MClosed |
$0 - $0
|
0
$0
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.67M- 97.89% |
$0 - $0
|
36.1K
$19.5K
|